Robertson, A., Kristoffersen, G., Cantilena, S., Petritsch, C. K., Sorani, E. (2026). GLIX1: A first-in-class oral molecule targeting the DNA damage response by restoring TET2 activity.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e14072